A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs - Contacts and Locations

A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

This study has been completed.

Study NCT00002442. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002442

Locations


United States, California
	Palo Alto Veterans Affairs Health Care System
	Palo Alto, California, United States, 94304
	AIDS Healthcare Foundation
	Los Angeles, California, United States, 90027

United States, District of Columbia
	Dupont Circle Physicians Group
	Washington, District of Columbia, United States, 200091104

United States, Florida
	IDC Research Initiative
	Altamonte Springs, Florida, United States, 32701
	Steinhart Medical Associates
	Miami, Florida, United States, 33133
	North Broward Hosp District
	Fort Lauderdale, Florida, United States, 33316

United States, Illinois
	Northwestern Univ Med School
	Chicago, Illinois, United States, 60611

United States, New York
	St Lukes - Roosevelt Hosp Ctr
	New York, New York, United States, 10019
	Saint Vincents Hosp
	New York, New York, United States, 10011

United States, Pennsylvania
	MCP Hahnemann Univ Hosp
	Philadelphia, Pennsylvania, United States, 19102

United States, Texas
	Univ TX Galveston Med Branch
	Galveston, Texas, United States, 77550
	Southwest Infectious Disease Association / PA
	Dallas, Texas, United States, 75225

Sponsors and Collaborators

Glaxo Wellcome